Medical communications Archives - Porterhouse Medical

18 November 2019

Antibiotic resistance: The silent pandemic

Today, 18 November, marks the start of World Antibiotic Awareness Week, an annual event that aims to improve awareness of one of the biggest threats to global health today: antibiotic resistance

5 November 2019

New writer brings pharmacy expertise to Porterhouse Medical Group

We delighted to welcome Lucy Liveston to our growing scientific services team.

23 October 2019

From valued intern to respected manager

Big congratulations to Elliott on his promotion! Once a valued intern, now a respected manager.

Jon Hallows shares his experience as a parent who's son has been diagnosed with PANDAS

8 October 2019

PANDAS/PANS Awareness Day: A parent’s story

To help raise awareness and understanding of these rare and often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS

26 September 2019

Focus on age-related macular degeneration

To support National Eye Health Week and World Retina Day, our article aims to promote good eye health and raise awareness for those affected by age-related macular degeneration (AMD)

23 September 2019

Growth and innovation in design and digital tech at Porterhouse

We are delighted to announce that Richard Oakham has been promoted to the role of Creative Director.

Jeans for Genes Day 2019_Huntington's disease

19 September 2019

Jeans for Genes Day: A spotlight on Huntington’s Disease

To support Jeans for Genes Day 2019, here we focus on Huntington’s disease to raise awareness for the children and their families affected by this genetic disorder.

18 September 2019

Diligence and dedication pays off: Another promotion in the Scientific Services team

We are delighted to announce another well-deserved promotion in our Scientific Services team

12 September 2019

Tapping the potential of rare diseases: A journey into uncharted territory

Porterhouse Medical looks at some of the opportunities and challenges presented by the rare disease market, and how successfully navigating the space requires a different approach to medical communications.